Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Short-read Sequencing Market, By Application
7.1. Short-read Sequencing Market, by Application, 2020-2028
7.1.1. Oncology
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Clinical Investigation
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Reproductive Health
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. HLA Typing/Immune System Monitoring
7.1.4.1. Market Revenue and Forecast (2016-2028)
7.1.5. Metagenomics, Epidemiology & Drug Development
7.1.5.1. Market Revenue and Forecast (2016-2028)
7.1.6. Agrigenomics & Forensics
7.1.6.1. Market Revenue and Forecast (2016-2028)
7.1.7. Consumer Genomics
7.1.7.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Short-read Sequencing Market, By End User
8.1. Short-read Sequencing Market, by End User, 2020-2028
8.1.1. Academic Research
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Clinical Research
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Hospitals & Clinics
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Pharma & Biotech Entities
8.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Short-read Sequencing Market, By Technology
9.1. Short-read Sequencing Market, By Technology , 2020-2028
9.1.1. Next-Generation Sequencing
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Sanger Sequencing
9.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Short-read Sequencing Market, By Product
10.1. Short-read Sequencing Market, By Product, 2020-2028
10.1.1. Instruments
10.1.1.1. Market Revenue and Forecast (2016-2028)
10.1.2. Consumables
10.1.2.1. Market Revenue and Forecast (2016-2028)
10.1.3. Services
10.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 11. Global Short-read Sequencing Market, By Workflow
11.1. Short-read Sequencing Market, By Workflow, 2020-2028
11.1.1. Pre-Sequencing
11.1.1.1. Market Revenue and Forecast (2016-2028)
11.1.2. Sequencing
11.1.2.1. Market Revenue and Forecast (2016-2028)
11.1.3. Data Analysis
11.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 12. Global Short-read Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Application (2016-2028)
12.1.2. Market Revenue and Forecast, by End User (2016-2028)
12.1.3. Market Revenue and Forecast, By Technology (2016-2028)
12.1.4. Market Revenue and Forecast, By Product (2016-2028)
12.1.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Application (2016-2028)
12.1.6.2. Market Revenue and Forecast, by End User (2016-2028)
12.1.6.3. Market Revenue and Forecast, By Technology (2016-2028)
12.1.6.4. Market Revenue and Forecast, By Product (2016-2028)
12.1.6.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, by Application (2016-2028)
12.1.7.2. Market Revenue and Forecast, by End User (2016-2028)
12.1.7.3. Market Revenue and Forecast, By Technology (2016-2028)
12.1.7.4. Market Revenue and Forecast, By Product (2016-2028)
12.1.7.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Application (2016-2028)
12.2.2. Market Revenue and Forecast, by End User (2016-2028)
12.2.3. Market Revenue and Forecast, By Technology (2016-2028)
12.2.4. Market Revenue and Forecast, By Product (2016-2028)
12.2.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Application (2016-2028)
12.2.6.2. Market Revenue and Forecast, by End User (2016-2028)
12.2.6.3. Market Revenue and Forecast, By Technology (2016-2028)
12.2.6.4. Market Revenue and Forecast, By Product (2016-2028)
12.2.6.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, by Application (2016-2028)
12.2.7.2. Market Revenue and Forecast, by End User (2016-2028)
12.2.7.3. Market Revenue and Forecast, By Technology (2016-2028)
12.2.7.4. Market Revenue and Forecast, By Product (2016-2028)
12.2.7.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, by Application (2016-2028)
12.2.8.2. Market Revenue and Forecast, by End User (2016-2028)
12.2.8.3. Market Revenue and Forecast, By Technology (2016-2028)
12.2.8.4. Market Revenue and Forecast, By Product (2016-2028)
12.2.8.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, by Application (2016-2028)
12.2.9.2. Market Revenue and Forecast, by End User (2016-2028)
12.2.9.3. Market Revenue and Forecast, By Technology (2016-2028)
12.2.9.4. Market Revenue and Forecast, By Product (2016-2028)
12.2.9.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Application (2016-2028)
12.3.2. Market Revenue and Forecast, by End User (2016-2028)
12.3.3. Market Revenue and Forecast, By Technology (2016-2028)
12.3.4. Market Revenue and Forecast, By Product (2016-2028)
12.3.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Application (2016-2028)
12.3.6.2. Market Revenue and Forecast, by End User (2016-2028)
12.3.6.3. Market Revenue and Forecast, By Technology (2016-2028)
12.3.6.4. Market Revenue and Forecast, By Product (2016-2028)
12.3.6.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, by Application (2016-2028)
12.3.7.2. Market Revenue and Forecast, by End User (2016-2028)
12.3.7.3. Market Revenue and Forecast, By Technology (2016-2028)
12.3.7.4. Market Revenue and Forecast, By Product (2016-2028)
12.3.7.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, by Application (2016-2028)
12.3.8.2. Market Revenue and Forecast, by End User (2016-2028)
12.3.8.3. Market Revenue and Forecast, By Technology (2016-2028)
12.3.8.4. Market Revenue and Forecast, By Product (2016-2028)
12.3.8.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, by Application (2016-2028)
12.3.9.2. Market Revenue and Forecast, by End User (2016-2028)
12.3.9.3. Market Revenue and Forecast, By Technology (2016-2028)
12.3.9.4. Market Revenue and Forecast, By Product (2016-2028)
12.3.9.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Application (2016-2028)
12.4.2. Market Revenue and Forecast, by End User (2016-2028)
12.4.3. Market Revenue and Forecast, By Technology (2016-2028)
12.4.4. Market Revenue and Forecast, By Product (2016-2028)
12.4.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Application (2016-2028)
12.4.6.2. Market Revenue and Forecast, by End User (2016-2028)
12.4.6.3. Market Revenue and Forecast, By Technology (2016-2028)
12.4.6.4. Market Revenue and Forecast, By Product (2016-2028)
12.4.6.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, by Application (2016-2028)
12.4.7.2. Market Revenue and Forecast, by End User (2016-2028)
12.4.7.3. Market Revenue and Forecast, By Technology (2016-2028)
12.4.7.4. Market Revenue and Forecast, By Product (2016-2028)
12.4.7.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, by Application (2016-2028)
12.4.8.2. Market Revenue and Forecast, by End User (2016-2028)
12.4.8.3. Market Revenue and Forecast, By Technology (2016-2028)
12.4.8.4. Market Revenue and Forecast, By Product (2016-2028)
12.4.8.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, by Application (2016-2028)
12.4.9.2. Market Revenue and Forecast, by End User (2016-2028)
12.4.9.3. Market Revenue and Forecast, By Technology (2016-2028)
12.4.9.4. Market Revenue and Forecast, By Product (2016-2028)
12.4.9.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Application (2016-2028)
12.5.2. Market Revenue and Forecast, by End User (2016-2028)
12.5.3. Market Revenue and Forecast, By Technology (2016-2028)
12.5.4. Market Revenue and Forecast, By Product (2016-2028)
12.5.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Application (2016-2028)
12.5.6.2. Market Revenue and Forecast, by End User (2016-2028)
12.5.6.3. Market Revenue and Forecast, By Technology (2016-2028)
12.5.6.4. Market Revenue and Forecast, By Product (2016-2028)
12.5.6.5. Market Revenue and Forecast, By Workflow (2016-2028)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, by Application (2016-2028)
12.5.7.2. Market Revenue and Forecast, by End User (2016-2028)
12.5.7.3. Market Revenue and Forecast, By Technology (2016-2028)
12.5.7.4. Market Revenue and Forecast, By Product (2016-2028)
12.5.7.5. Market Revenue and Forecast, By Workflow (2016-2028)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Hoffmann-La Roche AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Qiagen N.V.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Illumina, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Genewiz
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Genscript Biotech Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. 10x Genomics
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Macrogen, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Agilent Technologies
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BGI Genomics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Fasteris SA
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. GE healthcare
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms